Ellen Weisberg, and Martin Sattler. 2012. “A Novel Combination Therapy Approach for the Treatment of Acute Myeloid Leukemia: The Multi-Kinase Inhibitor Sorafenib and the HDM2 Inhibitor Nutlin-3”. Haematologica 97 (11). Pavia, Italy, 1620-21. https://doi.org/10.3324/haematol.2012.078451.